Abstract:Background and purpose Systemic upregulation of inflammatory cytokines is characteristic of critical severe hand, foot, and mouth disease (HFMD) with pulmonary edema. Thus, immunomodulatory medicines such as steroids, including methylprednisolone, have been proposed to treat patients with severe HFMD in China, because it is postulated that inflammatory cytokines play a role in the development of severe complications. This study is to further investigate the inflammatory response in the relatively mild HFMD patients, and whether steroid treatment has a beneficial effect on the suppression of inflammation in HFMD patients. Method We measured the levels of 50 kinds of chemokines, cytokines, growth factors and soluble receptors in serum samples from control patients without HFMD and the HFMD patients with or without prior treatment of intravenous methylprednisolone. Results Our present study found that even relatively mild HFMD patients without central nervous system (CNS) complications had elevated serum levels of inflammatory cytokines, including interleukin (IL)-3, IL-6, IL-12p40, and tumor necrosis factor (TNF)-, which suggested systemic inflammation. In contrast, these patients also have decreased levels of other serum biomarkers, including IL-1Ra, IL-8, IL-16, soluble ICAM-1, CXCL-1, and CCL27. The dysregulation of cytokine and chemokine expression may be involved in CNS complications and unbalanced circulating leukocytes in HFMD patients. Surprisingly, patients treated with methylprednisolone had no difference in the expression levels of HFMD-associated biomarkers instead had slightly increased levels of IL-17A, which was not associated with the occurrence of HFMD. Conclusion Whether steroid treatment has any beneficial effect on the prognosis of HFMD patients requires to be further investigated. Author Summary Systemic inflammation is characteristic of severe hand, foot, and mouth disease (HFMD). Steroids are considered immunomodulators and have been officially recommended to treat the severe HFMD patients with CNS complications in China. So far, it is uncertain whether steroid treatment has an immunomodulatory role in inflammation in HFMD patients and has a real beneficial effect on their prognosis. This study revealed that even relatively mild HFMD patients without CNS complications had elevated inflammation. Unexpectedly, the inflammatory cytokine levels in patients treated with methylprednisolone, one kind of steroid, were not significantly different from those in patients without the treatment. Rather, the treated patients tended to have elevated levels of IL-17A, whose expression levels were actually not significantly associated with the presence of HFMD. IL-17A is known to play a role in the pathogenesis of CNS-related inflammatory diseases. Altogether, our study does not support the presumption that steroids have beneficial effect on the prognosis of HFMD patients by inhibiting systemic inflammation.

Clinical observation and nursing care of children with severe hand, foot and mouth disease receiving inhalation of recombinant human interferon α-1b

Changes and significances of cytokines and immunoglobulin in serum in children with hand-foot-mouth disease

A Randomized Control Trial of Xiyanping Injection in Treatment of Children with Hand, Foot and Mouth Disease

Efficacy and safety analysis of nebulized recombinant human interferon α1b in treatment of children with bronchiolitis

Xiyanping injection therapy for children with mild hand foot and mouth disease: a randomized controlled trial

Study of Interferon on Children Respiratory Infection

Clinical Observation on Efficacy of Xiyanping Injection and Reduning Injection in Treatment of Mild Cases of Hand-Foot-mouth Disease

[Effect of Reducing Injection on HFMD in Children: a Randomized Controlled Trial].

Clinical Significance Of Inflammatory Cytokine And Chemokine Expression In Hand, Foot And Mouth Disease

Effect of integrated Chinese and Western medicine therapy on severe hand, foot and mouth disease: A prospective, randomized, controlled trial

Clinical efficacy and safety of Yanhuning in the treatment of children’ s hand-foot-and-mouth disease

Curative Effects of Immunoglobulin in the Treatment of the Sever Hand-foot-mouth Disease

Efficacy and Safety of Recombinant Human Interferon α1b Injection Inhaling as Adjuvant Therapy for Bronchiolitis in Infants:A Systematic Review and Meta-analysis

A Multi-Center Randomized Prospective Study on the Treatment of Infant Bronchiolitis with Interferon Α1b Nebulization

Granule treatment of children with hand,foot and mouth disease to the blue-inflammatory efficacy of oral Poribavirin

Application Effect of Medical Care Integration Combined with Family Intervention under the Evidence-Based Nursing Mode on Child Patients with Severe Hand-Foot-Mouth Disease and Its Influence on Intestinal Function

The cytokine and chemokine profiles in patients with hand, foot and mouth disease of different severities in Shanghai, China, 2010.

Clinical Efficacy of Early Administration of Human Immunoglobulin on Children with Severe Hand-foot-mouth Disease

Comparative Study of the Cytokine/Chemokine Response in Children with Differing Disease Severity in Enterovirus 71-Induced Hand, Foot, and Mouth Disease

Efficacy and safety of interferon α-2b spray for herpangina in children: A randomized, controlled trial